Eye exam study measuring macular pigment in specific eye disease
Part of Skin clinical trials.
This study measures a pigment in the eye and also looks at other body tissues in people who have a specific inherited eye condition called adult vitelliform dystrophy. It may help researchers better understand the disease and how it can be confused with early age-related macular degeneration.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 7 or older
- Be coming to the Moran Eye Center for a routine dilated eye exam
- Have adult vitelliform dystrophy (a specific inherited eye condition)
- You should not be under age 7
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study focuses on people age 50+ with early “wasting away” changes in the macula (central retina) called atrophic lesions. It aims to better understand how these early changes progress and how they affect vision testing, which may help improve future treatments.
This study looks at how different eye tests (OCT and mf-ERG) can help measure vision in people with macular dystrophy. It may help doctors understand the condition better.
This study tests whether a supplement containing lutein, zeaxanthin, and meso-zeaxanthin can increase the amount of these nutrients in your skin. You will take the supplement and a placebo at different times to see if there is a difference.
This study collects samples like blood and a small skin biopsy (and sometimes urine, hair, or saliva) to better understand causes of eye diseases. The goal is to study eye conditions and may help researchers build better tests or treatments.
This study uses a special vision test called microperimetry to track how well the macula (the center of the retina) works in people with certain eye conditions like geographic atrophy or diabetic eye disease. Healthy volunteers are also needed for comparison. The goal is to understand how these conditions affect retinal function over time.
This trial is studying people with BEST1-associated vitelliform macular dystrophy, a genetic eye condition affecting central vision. It will involve several eye-related study visits over about three years, aiming to better understand the condition and how it is managed.
Hear when a new Macular Pigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.